Liquid Biopsy in Advanced NSCLC

Meeting Host

Foundation Medicine

Description

When

July 23, 2024 - 12:30 p.m. ET and 3:30 p.m. ET

Where

A Medical Education Webinare Series

Meeting Details

When a liquid biopsy report identifies a targetable driver, treatment decisions are clear. When there is no driver identified, the next steps are more uncertain. Expert speakers will present their perspectives on liquid biopsy for treatment selection in NSCLC and discuss emerging biomarker ctDNA tumor fraction reported on Foundation Medicine's liquid biopsy test.

Presented by

• Hatim Husain, MD
  Internationally Recognized Expert in Lung Cancer
• Holli Dilks, PhD
  Senior Director, Medical Affairs
  Foundation Medicine
• Jennifer Mills, PhD
  Moderator
  Vice President, Medical Affairs
  Foundation Medicine

Registration

Register Now